Fundz

Vyriad, Inc. reported raising $24.4 Million in an initial SEC Form D filing, from an offering of $37.8 Million

PRIVATENov 14, 2019$24.4M of $37.8M raised

Amount Raised

$24.4 Million

$24.4 Million sold, per SEC Form D (first sale Nov 14, 2019)

Round Type

Venture

RochesterBiotechnologyHealth CareScience And Engineering

Quick answer

Vyriad raised $24.4 Million in a funding round, dated November 14, 2019. Vyriad is based in Rochester, New York, United States.

How much did Vyriad raise?
Vyriad raised $24.4 Million in a funding round on November 14, 2019.
What does Vyriad do?
Vyriad is a clinical-stage biotechnology company developing targeted genetic medicines for cancer and other serious diseases.
Where is Vyriad based and how big is it?
Vyriad is based in Rochester, New York, United States. Fundz records about 52 employees.
Who are the decision-makers at Vyriad?
Fundz holds 2 contacts at Vyriad, including the EVP. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Biotechnology around the same time

Companies in the same sectors as Vyriad that raised within 45 days of this round, from Fundz verified event records.

  • Advanced NanoTherapies raised $640K (Seed) on December 9, 2019.
  • Viome raised $36M on November 27, 2019.
  • Cardurion Pharmaceuticals raised $128M on November 20, 2019.
  • RedHill Biopharma Ltd raised $48M on November 6, 2019.
  • Viracta Therapeutics raised $17M on November 5, 2019.
  • Cardiff Oncology raised $5M on October 30, 2019.

Who to call at Vyriad, and when

A new round usually means Vyriad is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vyriad raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vyriad, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vyriad. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vyriad

Location

2900 37th Street NW

Rochester, New York, United States

About

Vyriad is a clinical-stage biotechnology company developing targeted genetic medicines for cancer and other serious diseases. The company uses engineered viruses, viral vectors, and viral envelope glycoproteins to deliver therapeutic genes directly to selected cells. It has ongoing corporate partnerships with Regeneron Pharmaceuticals and Novartis. Vyriad’s developmental programs include oncolytic virotherapy, in vivo gene therapy, and gene-editing applications, with ongoing Phase 1–2 trials across multiple cancer indications. Vyriad is a privately held company based in Rochester, Minnesota and was co-founded by Mayo Clinician-Scientists, Dr. Stephen Russell and Dr. Kah-Whye Peng, to further develop and bring into clinical trials a set of research breakthroughs in their gene and virus therapy research labs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vyriad raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsLuke R., EVPSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Vyriad's next move

See what Strategic adds

Vyriad raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.